1 – 24 of 24
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia
(
- Contribution to journal › Article
- 2017
-
Mark
Improved positioning and detectability of microparticles in droplet microfluidics using two-dimensional acoustophoresis
2017) Micromechanics and Microsystems Europe Conference, 2016 In Journal of Micromechanics and Microengineering 27(8).(
- Contribution to journal › Article
- 2016
-
Mark
Two-dimensional acoustic focusing of microparticles in two-phase droplet-based microfluidic systems increases particle detectability
2016) 20th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2016 p.713-714(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 1998
-
Mark
Characterization of bacteriophages by the use of BIAcore(TM) and Origen Analyzer
(
- Contribution to journal › Article
-
Mark
Exploiting sequence space : Shuffling in vivo formed complementarity determining regions into a master framework
(
- Contribution to journal › Article
- 1996
-
Mark
Structural domains involved in human cytomegalovirus glycoprotein B-mediated cell-cell fusion
(
- Contribution to journal › Article
-
Mark
Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures
(
- Contribution to journal › Article
-
Mark
In vitro immunization of naive human B cells yields high affinity immunuglobulin G antibodies as illustrated by phage display
(
- Contribution to journal › Article
- 1995
-
Mark
Molecular characterization of human monoclonal antibodies specific for the human cytomegalovirus : Relationship of variable region sequence to antigen specificity and rheumatoid factor-associated idiotype expression
(
- Contribution to journal › Article
-
Mark
Generation of diversity in a human anti-viral response
(
- Contribution to journal › Article
-
Mark
A point mutation in a murine immunoglobulin V-region strongly influences the antibody yield in Escherichia coli
(
- Contribution to journal › Article
-
Mark
Human antibody reactivity against the lower matrix protein (pp65) produced by cytomegalovirus
(
- Contribution to journal › Article
- 1994
-
Mark
Site-directed primary in vitro immunization : Production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors
(
- Contribution to journal › Article
-
Mark
Intra- and extracellular expression of an scFv antibody fragment in E. coli : Effect of bacterial strains and pathway engineering using GroES/L chaperonins
(
- Contribution to journal › Article
- 1993
-
Mark
Fine specificity and neutralizing activity of human serum antibodies directed to the major antigenic region on gp 116 of human cytomegalovirus
(
- Contribution to journal › Article
-
Mark
Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines
(
- Contribution to journal › Article
- 1992
-
Mark
Epstein-Barr virus-induced transformation of human B lymphocytes : the effect of l-leucyl-l-leucine methyl ester on inhibitory T cell populations
(
- Contribution to journal › Article
-
Mark
Human MoAbs produced from normal, HIV-1-negative donors and specific for glycoprotein gp120 of the HIV-1 envelope
(
- Contribution to journal › Article
- 1990
-
Mark
Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
(
- Contribution to journal › Article
-
Mark
Systemic and intraocular uptake of spantide, a tachykinin antagonist, following topical application to the rabbit eye.
(
- Contribution to journal › Article
-
Mark
Pharmacokinetics of carbetocin, a long-acting oxytocin analogue, in nonpregnant women
(
- Contribution to journal › Article
- 1989
-
Mark
Effect of viscosity on the pharmacokinetics and biological response to intranasal desmopressin.
(
- Contribution to journal › Article
- 1988
-
Mark
Effects of concentration and volume on nasal bioavailability and biological response to desmopressin.
(
- Contribution to journal › Article
- 1985
-
Mark
IgG with a deviant conformation in serum and synovial fluid from rheumatoid arthritis patients
(
- Contribution to journal › Article